Services Startup-Centred Regulatory Support Regulatory Spark | Early-Stage Regulatory Roadmap for Biotech Innovators
Investor-ready regulatory guidance for early-stage innovators.
Know how you’ll reach patients before you pitch the product.
Regulatory Spark is a fixed-fee, fast-turnaround regulatory service from DLRC, designed to help early-stage innovators understand their likely route to clinic before key funding, development, or investor decisions are made.
In just 1 to 2 weeks, innovators receive a practical regulatory toolkit, including a high-level product classification, a path-to-clinic roadmap, headline data requirements, key regulatory risks, and an investor-ready summary.
Early decisions around product classification, evidence generation and development planning can shape the future of your programme. Without early regulatory input, development plans can be built on assumptions that later need to be revisited, leading to delays, additional costs and avoidable setbacks. Regulatory Spark helps you identify key regulatory considerations early, so you can move forward with greater confidence.
*MHRA advice given at the MHRA Innovation Meeting held at Babraham Research Campus on June 24th 2026
Book a discovery call
For early-stage innovators, regulatory planning is not just a technical exercise. It supports your funding story, shapes your development priorities, and gives investors confidence that you understand the path ahead.
Regulatory Spark helps you identify the key regulatory questions early, so you can make better decisions before significant time and budget are committed.
Regulatory Spark provides an early, high-level view. It is not intended to replace a full regulatory gap analysis or detailed development strategy, but it gives early-stage teams a practical and credible first step.
Regulatory Spark gives early-stage innovators a practical regulatory toolkit to support product development, investor conversations and future planning. It provides a clear, high-level view of your likely regulatory pathways across the UK, EU, and US, supported by senior DLRC regulatory insight and delivered in a focused, founder-friendly format.
DLRC combines regulatory and scientific expertise with practical development experience across the UK, EU, and US. Regulatory Spark gives early-stage innovators access to senior strategic input in a format that is clear, focused, and designed for limited time, budget, and runway.
This is not an open-ended consultancy engagement. It is a fixed-fee package created to help you make better early decisions, prepare for investor conversations and understand the regulatory path ahead.
You know what is included and what it will cost from the start
Your output will be prepared in 1 to 2 weeks, once the relevant information is available
The final materials are designed to be practical, clear, and useful for investors, accelerators, or grant discussions
As your programme develops, Regulatory Spark can lead to The Regulatory Catalyst or wider DLRC support for deeper preclinical, CMC, clinical development strategy and CTA or IND planning.
Following a short discovery call, DLRC will confirm a fixed quotation before any work begins. This gives early-stage teams a clear, focused route into senior regulatory advice without committing to a larger bespoke strategy engagement before they are ready.
Regulatory Spark is suitable for early-stage biotech innovators who need early regulatory clarity before fundraising, grant applications, accelerator programmes or further development planning.
It may be less suitable for larger or more advanced companies that need a full bespoke regulatory strategy, detailed gap analysis or later-stage development planning. These organisations may be better suited to The Regulatory Catalyst or wider DLRC regulatory support.
Regulatory Spark is a fixed-fee regulatory service from DLRC for early-stage innovators. It provides a high-level product classification and pathway, path-to-clinic roadmap, top regulatory risks, headline data requirements, investor-ready summary and a 60-minute founder review call.
Regulatory Spark is designed for early-stage innovators, including biotech/small molecule/advanced therapy founders, scientific founders, academic spin-outs and teams preparing for investor, accelerator or grant-funding conversations.
The package includes a high-level product classification, a path-to-clinic roadmap, an outline of regulatory risks, a mini TPP, an investor-ready summary and a 60-minute discussion with a senior consultant.
Regulatory Spark is designed to be delivered in 1 to 2 weeks, once the relevant information is available.
Regulatory Spark provides high-level regulatory insight across the UK, EU, and US.
No. Regulatory Spark provides a high-level overview of likely regulatory pathways, key risks and headline data requirements. It is designed as an early, focused first step rather than a full regulatory gap analysis or detailed development strategy.
A fixed-fee quotation is confirmed after a short discovery call and before work begins, with the exact figure depending on the product’s complexity.
Regulatory Spark can provide a clear upgrade path into The Regulatory Catalyst or wider DLRC support for deeper preclinical, CMC, clinical development strategy and CTA or IND planning.
Start with a clear regulatory roadmap, shaped for early-stage innovators and ready to support your next investor, accelerator or grant conversation.
